Showing results (211-220 of 252) with videos related to

Sort By:
Pageof 26
Phytochemistry|June 12, 2014
Chemical constituents of Abies delavayiXian-Wen Yang, Su-Mei Li, Yong-Li Li, et al.
Planta Medica|July 7, 2009
Chemical constituents of Dracocephalum forrestiiSu-Mei Li, Xian-Wen Yang, Yong-Li Li, et al.
Phytochemistry|July 2, 2008
Chemical constituents of Aeschynanthus bracteatus and their weak anti-inflammatory activitiesSu-Mei Li, Xian-Wen Yang, Yun-Heng Shen, et al.
Frontiers in Pharmacology|November 5, 2019
Induction Apoptosis of Erinacine A in Human Colorectal Cancer Cells Involving the Expression of TNFR, Fas, and Fas Ligand <i>via</i> the JNK/p300/p50 Signaling Pathway With Histone AcetylationKo-Chao Lee, Kam-Fai Lee, Shui-Yi Tung, et al.
Chemical Communications (Cambridge, England)|January 4, 2013
Pseudolarenone, an unusual nortriterpenoid lactone with a fused 5/11/5/6/5 ring system featuring an unprecedented bicyclo[8.2.1]tridecane core from Pseudolarix amabilisBo Li, De-Yun Kong, Yun-Heng Shen, et al.
Phytochemistry|October 6, 2012
Characterization of chlorinated valepotriates from Valeriana jatamansiSheng Lin, Zhong-Xiao Zhang, Tao Chen, et al.
Scientific Reports|January 15, 2021
Long-term risk of primary liver cancers in entecavir versus tenofovir treatment for chronic hepatitis BTe-Sheng Chang, Yao-Hsu Yang, Wei-Ming Chen, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|December 19, 2018
Expression of PRDX6 Correlates with Migration and Invasiveness of Colorectal Cancer CellsWen-Shih Huang, Cheng-Yi Huang, Meng-Chiao Hsieh, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|August 26, 2019
Incidence, risk factors and impact on virological response of anemia in chronic genotype 2 hepatitis C receiving sofosbuvir plus ribavirinChi-Ching Chen, Shui-Yi Tung, Kuo-Liang Wei, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 11, 2013
Efficacy and safety of pegylated interferon alfa-2b and ribavirin combination therapy versus pegylated interferon monotherapy in hemodialysis patients: a comparison of 2 sequentially treated cohortsPo-Lin Tseng, Te-Chuan Chen, Yu-Shu Chien, et al.
Pageof 26